Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending‐Dose Studies in Healthy Subjects
Cenobamate (YKP3089) is an antiepileptic drug recently approved by the Food and Drug Administration for the treatment of focal (partial‐onset) seizures in adults. The objectives of a first‐in‐human single‐ascending‐dose study and 3 multiple‐ascending‐dose studies were to characterize the pharmacokin...
Saved in:
Published in | Clinical pharmacology in drug development Vol. 9; no. 4; pp. 428 - 443 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!